Lv2
140 积分 2021-06-11 加入
In vitro and in vivo pharmacological profile of PL-3994, a novel cyclic peptide (Hept-cyclo(Cys-His-Phe-d-Ala-Gly-Arg-d-Nle-Asp-Arg-Ile-Ser-Cys)-Tyr-[Arg mimetic]-NH2) natriuretic peptide receptor-A agonist that is resistant to neutral endopeptidase and acts as a bronchodilator
16天前
已完结
Ularitide: A Natriuretic Peptide Candidate for the Treatment of Acutely Decompensated Heart Failure
21天前
已完结
Ularitide: A Natriuretic Peptide Candidate for the Treatment of Acutely Decompensated Heart Failure
21天前
已关闭
Ularitide: A Natriuretic Peptide Candidate for the Treatment of Acutely Decompensated Heart Failure
21天前
已关闭
Discovery of BAY 2413555, First Selective Positive Allosteric Modulator of the M2 Receptor to Restore Cardiac Autonomic Balance
21天前
已完结
神经性皮炎基层诊疗指南（2023年）
30天前
已完结
Does siRNA-based therapy require pegylated interferon-alfa-2a to cure HBV infection?
1个月前
已完结
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study
1个月前
已完结
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
1个月前
已完结
皖公网安备34019202002308
